Zenvia (NASDAQ:ZENV) versus Black Titan (NASDAQ:BTTC) Head to Head Survey

Zenvia (NASDAQ:ZENV) and Black Titan (NASDAQ:BTTC) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Analyst Ratings

This is a summary of current ratings and target prices for Zenvia and Black Titan, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zenvia	1	0	0	0	1.00
Black Titan	1	0	0	0	1.00

Volatility and Risk

Zenvia has a beta of 1.86, suggesting that its stock price is 86% more volatile than the S&P 500. Comparatively, Black Titan has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

Valuation and Earnings

This table compares Zenvia and Black Titan”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zenvia	$1.10 billion	0.02	-$28.67 million	($0.40)	-1.17
Black Titan	$2.68 million	1.20	-$4.71 million	($2.95)	-0.10

Black Titan has lower revenue, but higher earnings than Zenvia. Zenvia is trading at a lower price-to-earnings ratio than Black Titan, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Zenvia and Black Titan’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zenvia	-10.62%	-14.36%	-6.52%
Black Titan	N/A	N/A	N/A

Insider and Institutional Ownership

49.2% of Zenvia shares are owned by institutional investors. 78.4% of Zenvia shares are owned by company insiders. Comparatively, 0.7% of Black Titan shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

About Zenvia

Zenvia Inc. is a Brazilian technology company that provides customer experience and communications solutions for businesses. Its platform is designed to help companies manage interactions with customers across multiple digital channels, supporting activities such as marketing, sales, customer service and engagement. The company’s products and services include application programming interfaces (APIs) and communications-platform-as-a-service tools for SMS, WhatsApp, voice and other messaging channels.

About Black Titan

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.